Liyuan Ma

6PUBLICATIONS
2CO-AUTHORS
Haematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 15, 2026
IFN-γ Driven Hepatic Injury Exacerbates Mortality in NK/T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.

Yehua Yu, Liyuan Ma, Haifang Hang

|Feb 23, 2024
Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study.

Haifang Hang, Hui Zhou, Liyuan Ma

|Jun 23, 2023
BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis.

Ran Wu, Liyuan Ma

|Oct 12, 2020
Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis.

Ran Wu, Liyuan Ma

|Nov 30, 2019
Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.

Ran Wu, Chuanxu Liu, Xiaohui Deng

|Oct 24, 2019
Successful treatment of diffuse large B-cell lymphoma with secondary hemophagocytic lymphohistiocytosis by R-CHOP-E regimen: a case report.

Ran Wu, Xiaohui Deng, Siguo Hao

Pageof 1

Frequent Collaborators

1 joint publications

Yehua Yu

1 joint publications

Yuyang Pang